A new revelation by the US Centers for Disease Control and Prevention (CDC) states that two doses of the Pfizer Covid vaccine can help in protecting a 'rare but often serious' condition in children.

Pfizer vaccine protects children against this 'rare' Covid complication

After FDA, Centers for Disease Control Director Dr Rochelle Walensky has suggested the use of Pfizer booster doses for teenagers from 12 through 15 years of age.

Omicron update: CDC suggests Pfizer booster shot for kids aged 12 and above

The US Food and Drug Administration has authorised the use of a third dose of the Pfizer-BioNTech's COVID-19 vaccine for children ages 12 to 15, and reduced the wait time between initial vaccination and an extra dose from six months to five months for all ages.

US FDA authorises Pfizer COVID-19 vaccine booster for children ages 12 to 15

The US Food and Drug Administration has amended the use of Pfizer booster doses for teenagers from 12 through 15 years of age. It has also reduced the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 vaccine and a booster dose to at least five months.

Omicron update: FDA amends emergency use of Pfizer booster dose for more teens

The Food and Drug Administration is planning to broaden eligibility for coronavirus vaccine booster doses Monday, allowing 12- to 15-year-olds to receive third doses of Pfizer-BioNTech’s vaccine, according to people familiar with the agency’s deliberations.

FDA plans to allow 12- to 15-year-olds to receive Pfizer boosters

Israel on Thursday received first shipment of Pfizer's anti-Covid pill. Prime Minister Nafatali Bennett hailed it as critical to combat the Omicron threat. "Thanks to our rapid action, the drugs have arrived in Israel quickly and will assist us in getting past the peak of the coming Omicron wave," Bennett said.

First shipment of Pfizer's anti-Covid drug arrives in Israel

In a recent revelation, experts have said that antiviral pills against Covid, may not be safe for everyone. After doctors and pharmacists closely analysed the pills, they concluded that these pills can be life-threatening when taken with other medications, reports NBC.

Pfizer's pill against Covid can be dangerous when taken with other medications

US Food and Drug Administration on Wednesday gave a go-ahead to Pfizer's Covid pill for its use among high-risk people aged 12 and above. "Today's authorization introduces the first treatment for Covid-19 that is in the form of a pill that is taken orally -- a major step forward in the fight against this global pandemic," said FDA scientist Patrizia Cavazzoni.

USFDA gives go-ahead to Pfizer's Covid pill

The US has authorized Pfizer's anti-COVID pill. It has been authorized for people aged 12 and above who are at risk. Now the steps come as the country witnesses a surge in COVID cases.

US authorizes Pfizer's anti-COVID pill

Bernie Sanders claims investors of Pfizer & Moderna made $10 billion as news about Omicron spread. Through secret contracts & vaccine patents - vaccine makers want to control the prices of boosters. Palki Sharma tells you how they could profit from boosters and variants.

Gravitas: How Vaccine Makers could profit from boosters and variants

The United States has authorised Pfizer's anti-covid pill for people aged 12 or above who are at high risk, it's called Paxlovid; the pill comprises of two types of tablets.

US approves Pfizer's anti-covid pill for 12 years of age and above

United States authorizes Pfizer's anti-COVID pill,

The European Commission said on Sunday that European Union countries will get additional 20 million doses of Pfizer-BioNTech Covid vaccine to fight Omicron virus that is fast spreading.

To fight Omicron, EU to get 20 million extra vaccines

Pfizer Inc has said that its antiviral COVID-19 has about 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the Omicron variant of the coronavirus.

Pfizer covid-19 pill nearly 90% effective against Omicron variant of Coronavirus

Latest variant of coronavirus Omicron variant has been found in 57 countries across the world while scientists are still studying the transmissibility of the variant, concerns of Omicron are only increasing. In the latest, three-shot course can neutralize Omicron variant.

Pfizer: Booster promising against Omicron | Coronavirus News

A major real-world study has suggested that Pfizer Covid vaccine has weaker efficacy against the Omicron variant. The study revealed that the Pfizer vaccine had efficacy of just 70 per cent against hospitalisation.

Pfizer vaccine less effective against Omicron variant, claims study

A 26-year-old man's death in New Zealand has been linked to a side effect from Pfizer's Covid vaccine after he died within two weeks of receiving it. After taking his first dose, the person suffered from myocarditis, which is a rare inflammation of the heart muscle.

Young man's death in New Zealand linked to Pfizer Covid vaccine after he suffered from myocarditis

Amid growing concerns over the new Coronavirus (COVID-19) variant, Pfizer Inc said on Friday the pandemic could extend through next year. The vaccine making company also announced plans to come up with a three-dose vaccine regimen for children aged 2 to 16.

Pfizer says COVID-19 pandemic could extend to 2024

The Brazilian president Jair Bolsonaro has threatened to disclose identities of health officials who played a part in approving Covid vaccines for children. Bolsonaro's threat has come after Brazil’s health regulator, Anvisa, revealed that the organisations’s five directors had recently received death threats over the fact that they had played a part in approval of vaccinations for children aged between five and eleven.

Bolsonaro threatens disclosing names of officials who approved Covid jabs for children

On Thursday, a panel of US government-appointed medical experts unanimously recommended Pfizer's and Moderna's mRNA Covid vaccines over Johnson & Johnson's due to its weaker protection and greater risks.

Citing risk of clotting, US expert panel votes for the use of Moderna, Pfizer vaccines, over J&J

The European Medical Agency on Thursday gave go-ahead for emergency use of Pfizer's Covid pill. Formal approval is still pending. The initial go-ahead has been given to curb Omicron infection.

EU drug regulator gives go-ahead for Pfizer Covid pill's emergency use

After reports claimed Pfizer had shown a "shocking risk level" for its vaccine, a fact-check by AFP revealed it was an inaccurate claim and that there was no causal link established between the problems and the jabs.

Fact-check: Documents claiming Pfizer vaccine led to adverse effects are false

Pharma major Pfizer said on Tuesday that clinical trials showed that its Covid pill drastically reduces probability of hospitalisation and death among at-risk people.

Pfizer claims Covid pill drastically reduces severe infection

Pfizer said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalisations and deaths in high-risk patients.

Pfizer says its COVID-19 pill shows 90% efficacy, cuts hospitalisation risk

pfizer

Pfizer, News on Pfizer, stories on Pfizer, articles on Pfizer, Pfizer stories at Wion, Pfizer news, Pfizer latest news